Texas ran a medical cannabis program more restrictive than comparator states for a decade: three dispensing organizations, all in central Texas, selling mostly edibles, tinctures, and beverages capped at 0.5–1% THC by weight, with no overnight product storage allowed outside the home dispensary. A 2024 state-commissioned evaluation
Georgia's medical cannabis program spent years capped at 5% THC, with no smokable or vaporizable flower allowed. On July 1, 2026, that changed — GMCC says the new products are available at both dispensaries and independent pharmacies, though how consistently that's playing out at the pharmacy counter
Kentucky doesn't publish a revenue dashboard, but the real number exists — it surfaced in legislative testimony instead. OMC told the state legislature on July 2 that Kentucky had shipped $4.4 million worth of product to dispensaries as of June 11 — a wholesale figure, corrected here to roughly
Before Delaware's adult-use launch, Marijuana Commissioner Rob Coupe projected the state's legal cannabis market would reach $281 million in its first year — extrapolating existing medical patient spending (about $3,303/year per patient) across an estimated 85,000 future customers. Actual first-year sales came
New Hampshire's therapeutic cannabis program enrolled 16,846 patients as of June 2025 — up 14.6% in a single year, its strongest growth since the 2018–2020 expansion phase — served by three nonprofit operators holding four statutory Alternative Treatment Center certificates across seven dispensing locations. RSA 126-X:
South Dakota and North Dakota are, for cannabis-policy purposes, close to a matched pair: nearly identical Republican supermajorities, nearly identical median income and education, nearly identical rejection of adult-use legalization, and populations within 17% of each other. South Dakota's medical program still enrolls roughly double North
North Dakota's medical marijuana program sold $22.4 million in fiscal year 2024 through eight dispensaries supplied by exactly two manufacturers — the maximums state law permits without a regulatory finding that has never been made. Under the framework's assumptions, the legal channel captures roughly 11% of
Iowans spend an estimated three-quarters of a billion dollars a year on cannabis. About $13.7 million of it — 1.8% — passes through the state's five licensed dispensaries. The rest, roughly $760 million annually — about $2.1 million every day — is spending Iowa's medical channel
Louisiana's medical cannabis program runs on just two licensed producers supplying a hard-capped 30 dispensaries statewide. Wholesale distribution to pharmacies reached an estimated $90.9 million in the year ending June 2025 — a figure independently confirmed two ways, once by state tax collections and once by industry
Washington DC voters approved cannabis legalization in 2014 with 70% of the vote. Eleven years later, the city still has no licensed adult-use market. What it has instead is a medical program that functions as a de facto adult-use channel for anyone willing to register, a "gifting&
Missouri's cannabis market generated $1.52 billion in 2025 — $1.34 billion adult-use, $174 million medical — against an estimated resident demand the framework puts near 280 million grams. That works out to a blended price of about $5.42 per gram and resident capture north of 90%
Washington legalized adult-use cannabis in 2012 alongside Colorado and is now the clearest case study in what a mature, oversupplied, commodity-floor market looks like. FY2025 legal sales of roughly $1.18 billion against an estimated 387.6 million grams of resident demand work out to a blended all-